Co-management of Auditory Neuropathy Spectrum Disorder

Carmen Jamis, AuD, CCC-A is the senior pediatric audiologist on the hearing implant team in the head and neck institute at the Cleveland Clinic. She is a member of the International Ototoxicity Monitoring Group (IOMG) – Pediatric Cancer subgroup as well as the Northeast Ohio Regional Liaison for the Ohio Academy of Audiology. Prior to her current position, Dr. Jamis was on staff at Walter Reed National Military Medical Center in Bethesda, MD, and Children’s National Medical Center in Washington, DC. She was adjunct faculty at Gallaudet University and clinical faculty in the Otolaryngology Residency Program at Walter Reed. Dr. Jamis earned her Au.D. at Gallaudet University in Washington, DC. In 2014, she completed a residency in pediatric audiology at UPMC Children’s Hospital in Pittsburgh, PA. Dr. Jamis has a number of clinical and research interests including pediatric diagnostics, hearing implants, and early access to communication for children with hearing loss.

Financial Disclosures: Dr. Jamis receives compensation from the Cleveland Clinic as the Senior Pediatric and Hearing Implant Audiologist. She also received compensation from Hearing First to facilitate this course.

Non-financial disclosures: Dr. Jamis has no non-financial disclosures at this time.

Lindsay Zombek, MS, CCC-SLP, LSLS Cert AVT is the Supervisor of Speech Language Pathology-Academic Region and a Listening and Spoken Language Auditory Verbal Therapist in The Ear, Nose, and Throat Institute at University Hospitals Cleveland Medical Center in Cleveland, OH. She provides evaluation and therapy services for children and adults with hearing loss and presents on topics related to aural rehabilitation.

Financial Disclosures: Ms. Zombek receives compensation from the University Hospitals Cleveland Medical Center as Supervisor of Speech Language Pathology-Academic Region. She also received compensation from Hearing First to facilitate this course.

Non-financial disclosures: Ms. Zombek has no non-financial disclosures at this time.